Applied Biosystems / U.S. Department of Defense Contract for Prototype Instrument System to Identify Infectious Diseases Terminated

Published: Jun 04, 2007

FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, announced today that its contract with the U.S. Department of Defense surrounding the development of a prototype instrument system to improve the way infectious diseases are identified for epidemiological and biosecurity purposes has been terminated for the convenience of the government. Though Applied Biosystems had successfully completed all technical milestones required to date in the contract, the action was taken by the government after Applied Biosystems and the U.S. Air Force were unable to agree on an approach for further development and commercialization of an instrument system that could be derived from an AB prototype instrument. Applied Biosystems anticipates no material financial impact from the contract termination.

Back to news